Similar articles

• Addressing the Disparities in Prostate Cancer Care and Outcomes.

  Kittles R. Kittles R. Oncology (Williston Park). 2019 Jul 16;33(7):629377. Oncology (Williston Park). 2019. PMID: 31365747 No abstract available.
• Re: Prostate cancer and the androgen receptor.

  Coetzee GA, Ross RK. Coetzee GA, et al. J Natl Cancer Inst. 1994 Jun 1;86(11):872-3. doi: 10.1093/jnci/86.11.872. J Natl Cancer Inst. 1994. PMID: 8182772 No abstract available.
• Racial disparity of epidermal growth factor receptor expression in prostate cancer.

  Shuch B, Mikhail M, Satagopan J, Lee P, Yee H, Chang C, Cordon-Cardo C, Taneja SS, Osman I. Shuch B, et al. J Clin Oncol. 2004 Dec 1;22(23):4725-9. doi: 10.1200/JCO.2004.06.134. J Clin Oncol. 2004. PMID: 15570072
• Molecular genetics of prostate cancer: clinical applications.

  Morton RA Jr, Isaacs WB. Morton RA Jr, et al. J Natl Med Assoc. 1998 Nov;90(11 Suppl):S728-31. J Natl Med Assoc. 1998. PMID: 9828591 Free PMC article. Review. No abstract available.
• Steroid hormones and cancer: IV. Prostate cancer.

  Habib FK. Habib FK. Eur J Surg Oncol. 1997 Jun;23(3):264-8. doi: 10.1016/s0748-7983(97)92604-4. Eur J Surg Oncol. 1997. PMID: 9236904 Review.